<DOC>
	<DOCNO>NCT00897767</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample blood bone marrow patient cancer study laboratory may help doctor learn diagnose cancer determine patient 's eligibility treatment clinical trial . It may also help study cancer future . PURPOSE : This laboratory study collect tissue sample patient leukemia blood disorder plan enroll ECOG leukemia treatment clinical trial .</brief_summary>
	<brief_title>Collecting Tissue Samples From Patients With Leukemia Other Blood Disorders Planning Enroll ECOG Leukemia Treatment Clinical Trial</brief_title>
	<detailed_description>OBJECTIVES : - To provide mechanism sample collection submission diagnostic review determine eligibility patient suspect leukemia relate hematologic disorder enrollment ECOG leukemia clinical trial . - To obtain baseline sample correlative study outline parent clinical trial . OUTLINE : This cohort , multicenter study . Patients submit bone marrow and/or blood sample . The sample study determine patient ' eligibility ECOG leukemia treatment clinical trial . Samples may store future correlative study relate ECOG treatment clinical trial .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Candidate enrollment ECOG treatment clinical trial acute chronic leukemia Suspected clinical diagnosis protocol ID number treatment clinical trial consideration must submit ECOG 's Leukemia Translational Studies Laboratory ensure require antibody panel use functional assay perform Chosen ECOG treatment clinical trial must active accrue Patient must begin treatment ECOG treatment clinical trial Patient may concurrently enrol laboratory study treatment clinical trial immediate treatment medically necessary If subsequent diagnostic review alters original diagnosis , patient remove treatment clinical trial PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>atypical chronic myeloid leukemia , BCR-ABL1 negative</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>chronic myelomonocytic leukemia</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>juvenile myelomonocytic leukemia</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
	<keyword>progressive hairy cell leukemia , initial treatment</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult T-cell leukemia/lymphoma</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>refractory hairy cell leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>stage I adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage I chronic lymphocytic leukemia</keyword>
	<keyword>stage II adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage II chronic lymphocytic leukemia</keyword>
	<keyword>stage III adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage III chronic lymphocytic leukemia</keyword>
	<keyword>stage IV adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage IV chronic lymphocytic leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
	<keyword>T-cell large granular lymphocyte leukemia</keyword>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>acute undifferentiated leukemia</keyword>
	<keyword>mast cell leukemia</keyword>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>prolymphocytic leukemia</keyword>
	<keyword>untreated hairy cell leukemia</keyword>
</DOC>